Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2006

Open Access 01-12-2006 | Research article

Treating asthma with omega-3 fatty acids: where is the evidence? A systematic review

Authors: J Reisman, HM Schachter, RE Dales, K Tran, K Kourad, D Barnes, M Sampson, A Morrison, I Gaboury, J Blackman

Published in: BMC Complementary Medicine and Therapies | Issue 1/2006

Login to get access

Abstract

Background

Considerable interest exists in the potential therapeutic value of dietary supplementation with the omega-3 fatty acids. Given the interplay between pro-inflammatory omega-6 fatty acids, and the less pro-inflammatory omega-3 fatty acids, it has been thought that the latter could play a key role in treating or preventing asthma. The purpose was to systematically review the scientific-medical literature in order to identify, appraise, and synthesize the evidence for possible treatment effects of omega-3 fatty acids in asthma.

Methods

Medline, Premedline, Embase, Cochrane Central Register of Controlled Trials, CAB Health, and, Dissertation Abstracts were searched to April 2003. We included randomized controlled trials (RCT's) of subjects of any age that used any foods or extracts containing omega-3 fatty acids as treatment or prevention for asthma. Data included all asthma related outcomes, potential covariates, characteristics of the study, design, population, intervention/exposure, comparators, and co interventions.

Results

Ten RCT's were found pertinent to the present report.

Conclusion

Given the largely inconsistent picture within and across respiratory outcomes, it is impossible to determine whether or not omega-3 fatty acids are an efficacious adjuvant or monotherapy for children or adults. Based on this systematic review we recommend a large randomized controlled study of the effects of high-dose encapsulated omega-3 fatty acids on ventilatory and inflammatory measures of asthma controlling diet and other asthma risk factors. This review was limited because Meta-analysis was considered inappropriate due to missing data; poorly or heterogeneously defined populations, interventions, intervention-comparator combinations, and outcomes. In addition, small sample sizes made it impossible to meaningfully assess the impact on clinical outcomes of co-variables. Last, few significant effects were found.
Appendix
Available only for authorised users
Literature
1.
go back to reference McKeever TM, Britton J: Diet and asthma. Am J Respir Crit Care Med. 2004, 170: 725-729. 10.1164/rccm.200405-611PP.CrossRefPubMed McKeever TM, Britton J: Diet and asthma. Am J Respir Crit Care Med. 2004, 170: 725-729. 10.1164/rccm.200405-611PP.CrossRefPubMed
3.
go back to reference Simopoulos AP: The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother. 2002, 56: 365-379. 10.1016/S0753-3322(02)00253-6.CrossRefPubMed Simopoulos AP: The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother. 2002, 56: 365-379. 10.1016/S0753-3322(02)00253-6.CrossRefPubMed
4.
5.
go back to reference National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma Update on Selected Topics--2002. J Allergy Clin Immunol. 2002, 110: S141-S219. National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma Update on Selected Topics--2002. J Allergy Clin Immunol. 2002, 110: S141-S219.
6.
go back to reference Horrobin DF: Low prevalences of coronary heart disease (CHD), psoriasis, asthma and rheumatoid arthritis in Eskimos: are they caused by high dietary intake of eicosapentaenoic acid (EPA), a genetic variation of essential fatty acid (EFA) metabolism or a combination of both?. Med Hypotheses. 1987, 22: 421-428. 10.1016/0306-9877(87)90037-5.CrossRefPubMed Horrobin DF: Low prevalences of coronary heart disease (CHD), psoriasis, asthma and rheumatoid arthritis in Eskimos: are they caused by high dietary intake of eicosapentaenoic acid (EPA), a genetic variation of essential fatty acid (EFA) metabolism or a combination of both?. Med Hypotheses. 1987, 22: 421-428. 10.1016/0306-9877(87)90037-5.CrossRefPubMed
7.
go back to reference Gil A: Polyunsaturated fatty acids and inflammatory diseases. Biomed Pharmacother. 2002, 56: 388-396. 10.1016/S0753-3322(02)00256-1.CrossRefPubMed Gil A: Polyunsaturated fatty acids and inflammatory diseases. Biomed Pharmacother. 2002, 56: 388-396. 10.1016/S0753-3322(02)00256-1.CrossRefPubMed
8.
go back to reference Schachter HM, Reisman J, Tran K, Dales B, Kourad K, Barnes D, Sampson M, Morrison A, Gaboury I, Blackman J: Health Effects of Omega-3 Fatty Acids on Asthma. 2004, Rockville MD, AHRQ Publication No. 04-E013-2, Technology Assessment 91: Schachter HM, Reisman J, Tran K, Dales B, Kourad K, Barnes D, Sampson M, Morrison A, Gaboury I, Blackman J: Health Effects of Omega-3 Fatty Acids on Asthma. 2004, Rockville MD, AHRQ Publication No. 04-E013-2, Technology Assessment 91:
9.
go back to reference Woods RK, Thien FC, Abramson MJ: Dietary marine fatty acids (fish oil) for asthma in adults and children. Cochrane Database Syst Rev. 2002, CD001283- Woods RK, Thien FC, Abramson MJ: Dietary marine fatty acids (fish oil) for asthma in adults and children. Cochrane Database Syst Rev. 2002, CD001283-
10.
go back to reference Jadad AR: Randomised controlled trials. 1998, London, BMJ Publishing Group Jadad AR: Randomised controlled trials. 1998, London, BMJ Publishing Group
11.
go back to reference Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF: Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet. 1999, 354: 1896-1900. 10.1016/S0140-6736(99)04149-5.CrossRefPubMed Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF: Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet. 1999, 354: 1896-1900. 10.1016/S0140-6736(99)04149-5.CrossRefPubMed
12.
go back to reference Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ: Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials. 1996, 17: 1-12. 10.1016/0197-2456(95)00134-4.CrossRefPubMed Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ: Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials. 1996, 17: 1-12. 10.1016/0197-2456(95)00134-4.CrossRefPubMed
13.
go back to reference Schulz KF, Chalmers I, Hayes RJ, Altman DG: Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995, 273: 408-412. 10.1001/jama.273.5.408.CrossRefPubMed Schulz KF, Chalmers I, Hayes RJ, Altman DG: Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995, 273: 408-412. 10.1001/jama.273.5.408.CrossRefPubMed
14.
go back to reference Downs SH, Black N: The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998, 52: 377-384.CrossRefPubMedPubMedCentral Downs SH, Black N: The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998, 52: 377-384.CrossRefPubMedPubMedCentral
15.
go back to reference McDonald CV: Effect of fish-oil derived omega-3 fatty acid supplements on asthma control. Aust N Z J Med. 1990, 20: 526- McDonald CV: Effect of fish-oil derived omega-3 fatty acid supplements on asthma control. Aust N Z J Med. 1990, 20: 526-
16.
go back to reference Nagakura T, Matsuda S, Shichijyo K, Sugimoto H, Hata K: Dietary supplementation with fish oil rich in omega-3 polyunsaturated fatty acids in children with bronchial asthma. Eur Respir J. 2000, 16: 861-865. 10.1183/09031936.00.16586100.CrossRefPubMed Nagakura T, Matsuda S, Shichijyo K, Sugimoto H, Hata K: Dietary supplementation with fish oil rich in omega-3 polyunsaturated fatty acids in children with bronchial asthma. Eur Respir J. 2000, 16: 861-865. 10.1183/09031936.00.16586100.CrossRefPubMed
17.
go back to reference Hodge L, Salome CM, Hughes JM, Liu-Brennan D, Rimmer J, Allman M, Pang D, Armour C, Woolcock AJ: Effect of dietary intake of omega-3 and omega-6 fatty acids on severity of asthma in children. Eur Respir J. 1998, 11: 361-365. 10.1183/09031936.98.11020361.CrossRefPubMed Hodge L, Salome CM, Hughes JM, Liu-Brennan D, Rimmer J, Allman M, Pang D, Armour C, Woolcock AJ: Effect of dietary intake of omega-3 and omega-6 fatty acids on severity of asthma in children. Eur Respir J. 1998, 11: 361-365. 10.1183/09031936.98.11020361.CrossRefPubMed
18.
go back to reference Arm JP, Horton CE, Mencia-Huerta JM, House F, Eiser NM, Clark TJ, Spur BW, Lee TH: Effect of dietary supplementation with fish oil lipids on mild asthma. Thorax. 1988, 43: 84-92.CrossRefPubMedPubMedCentral Arm JP, Horton CE, Mencia-Huerta JM, House F, Eiser NM, Clark TJ, Spur BW, Lee TH: Effect of dietary supplementation with fish oil lipids on mild asthma. Thorax. 1988, 43: 84-92.CrossRefPubMedPubMedCentral
19.
go back to reference Okamoto M, Mitsunobu F, Ashida K, Mifune T, Hosaki Y, Tsugeno H, Harada S, Tanizaki Y: Effects of dietary supplementation with n-3 fatty acids compared with n-6 fatty acids on bronchial asthma. Intern Med. 2000, 39: 107-111.CrossRefPubMed Okamoto M, Mitsunobu F, Ashida K, Mifune T, Hosaki Y, Tsugeno H, Harada S, Tanizaki Y: Effects of dietary supplementation with n-3 fatty acids compared with n-6 fatty acids on bronchial asthma. Intern Med. 2000, 39: 107-111.CrossRefPubMed
20.
go back to reference Thien FC, Mencia-Huerta JM, Lee TH: Dietary fish oil effects on seasonal hay fever and asthma in pollen-sensitive subjects. Am Rev Respir Dis. 1993, 147: 1138-1143.CrossRefPubMed Thien FC, Mencia-Huerta JM, Lee TH: Dietary fish oil effects on seasonal hay fever and asthma in pollen-sensitive subjects. Am Rev Respir Dis. 1993, 147: 1138-1143.CrossRefPubMed
21.
go back to reference Stenius-Aarniala B, Aro A, Hakulinen A, Ahola I, Seppala E, Vapaatalo H: Evening primose oil and fish oil are ineffective as supplementary treatment of bronchial asthma. Ann Allergy. 1989, 62: 534-537.PubMed Stenius-Aarniala B, Aro A, Hakulinen A, Ahola I, Seppala E, Vapaatalo H: Evening primose oil and fish oil are ineffective as supplementary treatment of bronchial asthma. Ann Allergy. 1989, 62: 534-537.PubMed
22.
go back to reference Kirsch CM, Payan DG, Wong MY, Dohlman JG, Blake VA, Petri MA, Offenberger J, Goetzl EJ, Gold WM: Effect of eicosapentaenoic acid in asthma. Clin Allergy. 1988, 18: 177-187. 10.1111/j.1365-2222.1988.tb02857.x.CrossRefPubMed Kirsch CM, Payan DG, Wong MY, Dohlman JG, Blake VA, Petri MA, Offenberger J, Goetzl EJ, Gold WM: Effect of eicosapentaenoic acid in asthma. Clin Allergy. 1988, 18: 177-187. 10.1111/j.1365-2222.1988.tb02857.x.CrossRefPubMed
23.
go back to reference Emelyanov AF: Treatment of asthma with lipid extract of New Zealand green-lipped mussel: a randomised clinical trial. Eur Respir J. 2002, 20: 596-600. 10.1183/09031936.02.02632001.CrossRefPubMed Emelyanov AF: Treatment of asthma with lipid extract of New Zealand green-lipped mussel: a randomised clinical trial. Eur Respir J. 2002, 20: 596-600. 10.1183/09031936.02.02632001.CrossRefPubMed
24.
go back to reference Dry J, Vincent D: Effect of a fish oil diet on asthma: results of a 1-year double-blind study. Int Arch Allergy Appl Immunol. 1991, 95: 156-157.CrossRefPubMed Dry J, Vincent D: Effect of a fish oil diet on asthma: results of a 1-year double-blind study. Int Arch Allergy Appl Immunol. 1991, 95: 156-157.CrossRefPubMed
25.
go back to reference Hodge L: Effect of fish oil supplements on severity of asthma in children. Annu Sci Meet Thorac Soc Aust N Z. 1997 Hodge L: Effect of fish oil supplements on severity of asthma in children. Annu Sci Meet Thorac Soc Aust N Z. 1997
26.
go back to reference Payan DG, Wong MY, Chernov-Rogan T, Valone FH, Pickett WC, Blake VA, Gold WM, Goetzl EJ: Alterations in human leukocyte function induced by ingestion of eicosapentaenoic acid. J Clin Immunol. 1986, 6: 402-410. 10.1007/BF00915380.CrossRefPubMed Payan DG, Wong MY, Chernov-Rogan T, Valone FH, Pickett WC, Blake VA, Gold WM, Goetzl EJ: Alterations in human leukocyte function induced by ingestion of eicosapentaenoic acid. J Clin Immunol. 1986, 6: 402-410. 10.1007/BF00915380.CrossRefPubMed
27.
go back to reference Arm JP, Horton CE, Spur BW, Mencia-Huerta JM, Lee TH: The effects of dietary supplementation with fish oil lipids on the airways response to inhaled allergen in bronchial asthma. Am Rev Respir Dis. 1989, 139: 1395-1400.CrossRefPubMed Arm JP, Horton CE, Spur BW, Mencia-Huerta JM, Lee TH: The effects of dietary supplementation with fish oil lipids on the airways response to inhaled allergen in bronchial asthma. Am Rev Respir Dis. 1989, 139: 1395-1400.CrossRefPubMed
28.
go back to reference Mickleborough TD, Lindley MR, Ionescu AA, Fly AD: Protective effect of fish oil supplementation on exercise-induced bronchoconstriction in asthma. Chest. 2006, 129: 39-49. 10.1378/chest.129.1.39.CrossRefPubMed Mickleborough TD, Lindley MR, Ionescu AA, Fly AD: Protective effect of fish oil supplementation on exercise-induced bronchoconstriction in asthma. Chest. 2006, 129: 39-49. 10.1378/chest.129.1.39.CrossRefPubMed
Metadata
Title
Treating asthma with omega-3 fatty acids: where is the evidence? A systematic review
Authors
J Reisman
HM Schachter
RE Dales
K Tran
K Kourad
D Barnes
M Sampson
A Morrison
I Gaboury
J Blackman
Publication date
01-12-2006
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2006
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/1472-6882-6-26

Other articles of this Issue 1/2006

BMC Complementary Medicine and Therapies 1/2006 Go to the issue